About Annelyn O'Rourke
Form D filings for RenBio in 2024 list Annelyn O'Rourke as executive officer.
Annelyn O'Rourke first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Annelyn O'Rourke in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Annelyn O'Rourke works with at each company, as listed on that company's latest Form D.
RenBio, Inc. · Form D, Sep 6, 2024
JD
Jaap Goudsmit, M.D., Ph.D.
Director
RD
Rachel Liberatore, Ph.D.
President and Chief Scientific Officer, director
ZD
Zhi Hong, Ph.D.
Director
DT
Donald Tang
Director
WS
Walter Wang, Sr.
Director